Extended-spectrum β-lactamase-producing Shiga toxin gene (stx 1)-positive Escherichia coli O26:H11: A new concern

Journal of Clinical Microbiology

Volumn 43, Issue 3, 2005, Pages 1072-1075

  Ishii, Yoshikazu ^a   Kimura, Soichiro ^a   Alba, Jimena ^a   Shiroto, Katsuaki ^a   Otsuka, Masanobu ^b   Hashizume, Naotaka ^b   Tamura, Kazumichi ^c   Yamaguchi, Keizo ^a  

^a TOHO UNIVERSITY   (Japan)

^b TOHO UNIVERSITY OHASHI MEDICAL CENTER   (Japan)

^c NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AZTREONAM; BETA LACTAMASE; CEFALOTIN; CEFEPIME; CEFMETAZOLE; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPODOXIME; CEFTRIAXONE; CIPROFLOXACIN; CLAVULANIC ACID; FROPENEM; GENTAMICIN; IMIPENEM; KANAMYCIN; MINOCYCLINE; NALIDIXIC ACID; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; SHIGA TOXIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CONJUGATION; BACTERIUM ISOLATION; CASE REPORT; CHROMATOGRAPHY; CONTROLLED STUDY; DNA SEQUENCE; ESCHERICHIA COLI; FEMALE; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; NUCLEOTIDE SEQUENCE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SCHOOL CHILD; TRANSMISSION ELECTRON MICROSCOPY;

BETA-LACTAMASES; CHILD; CONJUGATION, GENETIC; ESCHERICHIA COLI; FEMALE; HUMANS; MICROBIAL SENSITIVITY TESTS; SHIGA TOXIN;

ESCHERICHIA COLI;

EID: 14944380844     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.43.3.1072-1075.2005     Document Type: Article

References (29)

1. AitMhand, R., A. Soukri, N. Moustaoui, H. Amarouch, N. ElMdaghri, D. Sirot, and M. Benbachir. 2002. Plasmid-mediated TEM-3 extended-spectrum β-lactamase production in Salmonella typhimurium in Casablanca. J. Antimicrob. Chemother. 49:169-172.
2. Ambler, R. P. 1980. The structure of β-lactamases. Philos. Trans. R. Soc. London Ser. B Biol. Sci. 289:321-331.
3. Baraniak, A., E. Sadowy, W. Hryniewicz, and M. Gniadkowski. 2002. Two different extended-spectrum β-lactamases (ESBLs) in one of the first ESBL-producing Salmonella isolates in Poland. J. Clin. Microbiol. 40:1095-1097.
4. Bettelheim, K. A., and L. Beutin. 2003. Rapid laboratory identification and characterization of verocytotoxigenic (Shiga toxin producing) Escherichia coli (VTEC/STEC). J. Appl. Microbiol. 95:205-217.
5. Beutin, L., G. Krause, S. Zimmermann, S. Kaulfuss, and K. Gleier. 2004. Characterization of Shiga toxin-producing Escherichia coli strains isolated from human patients in Germany over a 3-year period. J. Clin. Microbiol. 42:1099-1108.
6. 1c is the most common Shiga toxin 1 subtype among Shiga toxin-producing Escherichia coli isolates from sheep but not among isolates from cattle. J. Clin. Microbiol. 41:926-936.
7. Bush, K., G. A. Jacoby, and A. A. Medeiros. 1995. A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39:1211-1233.
8. 2), intimin (eaeA), and enterohemorrhagic Escherichia coli (EHEC) hemolysin (EHEC hlyA) genes in animal feces by multiplex PCR. Appl. Environ. Microbiol. 65:868-872.
9. Fratamico, P. M., S. K. Sackitey, M. Wiedmann, and M. Y. Deng. 1995. Detection of Escherichia coli O157:H7 by multiplex PCR. J. Clin. Microbiol. 33:2188-2191.
10. Gannon, V. P., S. D'Souza, T. Graham, R. K. King, K. Rahn, and S. Read. 1997. Use of the flagellar H7 gene as a target in multiplex PCR assays and improved specificity in identification of enterohemorrhagic Escherichia coli strains. J. Clin. Microbiol. 35:656-662.
11. Ishii, Y., A. Ohno, H. Taguchi, S. Imajo, M. Ishiguro, and H. Matsuzawa. 1995. Cloning and sequence of the gene encoding a cefotaxime- hydrolyzing class A β-lactamase isolated from Escherichia coli. Antimicrob. Agents Chemother. 39:2269-2275.
12. Kimura, S., M. Ishiguro, Y. Ishii, J. Alba, and K. Yamaguchi. 2004. Role of a mutation at position 167 of CTX-M-19 in ceftazidime hydrolysis. Antimicrob. Agents Chemother. 48:1454-1460.
13. Mulvey, M. R., G. Soule, D. Boyd, W. Demczuk, and R. Ahmed. 2003. Characterization of the first extended-spectrum β-lactamase-producing Salmonella isolate identified in Canada. J. Clin. Microbiol. 41:460-462.
14. Nagano, N., N. Shibata, Y. Saitou, Y. Nagano, and Y. Arakawa. 2003. Nosocomial outbreak of infections by Proteus mirabilis that produces extended-spectrum CTX-M-2 type β-lactamase. J. Clin. Microbiol. 41:5530-5536.
15. National Committee for Clinical Laboratory Standards. 2003. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically; approved standard, 6th ed., M7-A6. National Committee for Clinical Laboratory Standards, Wayne, Pa.
16. National Committee for Clinical Laboratory Standards. 2004. Performance standards for antimicrobial susceptibility testing; 12th informational supplement, M100-S14. National Committee for Clinical Laboratory Standards, Wayne, Pa.
17. Osek, J. 2003. Development of a multiplex PCR approach for the identification of Shiga toxin-producing Escherichia coli strains and their major virulence factor genes. J. Appl. Microbiol. 95:1217-1225.
18. Paton, J. C., and A. W. Paton. 1998. Pathogenesis and diagnosis of Shiga toxin-producing Escherichia coli infections. Clin. Microbiol. Rev. 11:450-479.
19. Poirel, L., T. Naas, I. Le Thomas, A. Karim, E. Bingen, and P. Nordmann. 2001. CTX-M-type extended-spectrum β-lactamase that hydrolyzes ceftazidime through a single amino acid substitution in the omega loop. Antimicrob. Agents Chemother. 45:3355-3361.
20. 2, eae, and tir in enterohemorrhagic Escherichia coli-induced diarrhea and intestinal inflammation in infant rabbits. Infect. Immun. 71:7129-7139.
21. Russo, T. A. 2001. Harrison's principles of internal medicine, 15th ed. McGraw-Hill Professional, New York, N.Y.
22. Samadpour, M., M. Kubler, F. C. Buck, G. A. Depavia, E. Mazengia, J. Stewart, P. Yang, and D. Alfi. 2002. Prevalence of Shiga toxin-producing Escherichia coli in ground beef and cattle feces from King County, Washington. J. Food Prot. 65:1322-1325.
23. Schroeder, C. M., J. Meng, S. Zhao, C. DebRoy, J. Torcolini, C. Zhao, P. F. McDermott, D. D. Wagner, R. D. Walker, and D. G. White. 2002. Antimicrobial resistance of Escherichia coli O26, O103, O111, O128, and O145 from animals and humans. Emerg. Infect. Dis. 8:1409-1414.
24. Shiomi, M., M. Togawa, K. Fujita, and R. Murata. 1999. Effect of early oral fiuoroquinolones in hemorrhagic colitis due to Escherichia coli O157:H7. Pediatr. Int. 41:228-232.
25. Shiraki, Y., N. Shibata, Y. Doi, and Y. Arakawa. 2004. Escherichia coli producing CTX-M-2 β-lactamase in cattle, Japan. Emerg. Infect. Dis. 10:69-75.
26. Tsuchizaki, N., J. Ishikawa, and K. Hotta. 2000. Colony PCR for rapid detection of antibiotic resistance genes in MRSA and enterococci. Jpn. J. Antibiot. 53:422-429.
27. Winokur, P. L., R. Canton, J. M. Casellas, and N. Legakis. 2001. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin. Infect. Dis. 32(Suppl 2):S94-S103.
28. Yagi, T., H. Kurokawa, K. Senda, S. Ichtyama, H. Ito, S. Ohsuka, K. Shibayama, K. Shimokata, N. Kato, M. Ohta, and Y. Arakawa. 1997. Nosocomial spread of cephem-resistant Escherichia coli strains carrying multiple Toho-1-like β-lactamase genes. Antimicrob. Agents Chemother. 41:2606-2611.
29. Yagi, T., H. Kurokawa, N. Shibata, K. Shibayama, and Y. Arakawa. 2000. A preliminary survey of extended-spectrum β-lactamases (ESBLs) in clinical isolates of Klebsiella pneumoniae and Escherichia coli in Japan. FEMS Microbiol. Lett. 184:53-56.